Remove 2006 Remove Cultivation Remove Microdosing Remove Treatment
article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. In 2006, the first research paper by Johns Hopkins was published on the positive long-term impact of using psilocybin in a therapeutic study.

article thumbnail

What seniors need to know before getting a medical marijuana card

The Cannigma

The percentage of Americans over 65 who had reported using cannabis in the past year had increased tenfold between 2006 to 2018, from 0.4% With a medical marijuana card you can also receive preferential treatment at some combined medical/adult use dispensaries. to 4.2%, according to a study published in February, 2020.

article thumbnail

Here’s What Neuroimaging Can Tell Us About the Psychedelic Experience

SpeedWeed

Psilocybin and LSD have shown a remarkable potential to help treatment-resistant depression. 2006): Another fMRI-enabled psychedelic study investigated the idea that MDMA users may be more impulsive than people that haven’t consumed the substance. There is no scientific evidence MDMA has a negative effect on long-term memory.